Regeneron authorized to use monoclonal antibody treatment in the USA

 Regeneron authorized to use monoclonal antibody treatment in the USA

The drug, administered in Trump in October, contains two powerful antibodies which, in preliminary studies, showed promising results in containing the infection.

US Food and Drug Administration (FDA) authorization limits use of the drug to persons over 12 who have tested positive for tes

Learn More

Redak staff

Leave a Reply

Your email address will not be published.